Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
kPyqBYHqt5etnhpW
